Free Trial

Heart Test Laboratories Q3 2023 Earnings Report

Heart Test Laboratories logo
$3.49 +0.02 (+0.61%)
As of 01/21/2025 03:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Heart Test Laboratories EPS Results

Actual EPS
-$16.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Heart Test Laboratories Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Heart Test Laboratories Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Heart Test Laboratories Earnings Headlines

Trump currency shock imminent
Trump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launched a $1.9 trillion move against the Fed. What comes next could have dramatic consequences.
HeartSciences Inc. HSCS (U.S.: Nasdaq)
Heart Test announces CMS included AI-ECG tech in 2025 OPPS final rule
See More Heart Test Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Heart Test Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heart Test Laboratories and other key companies, straight to your email.

About Heart Test Laboratories

Heart Test Laboratories (NASDAQ:HSCS), a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

View Heart Test Laboratories Profile

More Earnings Resources from MarketBeat